Hepatic Cell News Volume 6.41 | Nov 18 2022

    0
    18








    2022-11-18 | HCN 6.41


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.41 – 18 November, 2022
    TOP STORY

    Targeting Glutamine Metabolism in Hepatic Stellate Cells Alleviates Liver Fibrosis

    Modest overexpression of SIRT4 protected the liver from fibrosis by inhibiting the transformation of glutamate to 2-ketoglutaric acid in the tricarboxylic acid cycle, thereby reducing the proliferative activity of hepatic stellate cells.
    [Cell Death & Disease]

    Full Article
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    GALNT14-Mediated O-Glycosylation on PHB2 Serine-161 Enhances Cell Growth, Migration and Drug Resistance by Activating IGF1R Cascade in Hepatoma Cells

    Cell-based experiments showed that elevated levels of GALNT14 promoted HCC growth, migration, and resistance to anticancer drugs.
    [Cell Death & Disease]

    Full Article

    Hepatocellular Carcinoma Cells Loss Lenvatinib Efficacy In Vitro through Autophagy and Hypoxia Response-Derived Neuropilin-1 Degradation

    Researchers investigated the interplay among neuropilin-1, autophagy, and hypoxia in the development of lenvatinib resistance in HCC cell lines.
    [Acta Pharmacologica Sinica]

    Full Article

    Biglycan Promotes Hepatic Fibrosis through Activating Heat Shock Protein 47

    Human liver samples, Bgn–/0 mice and a human LX-2 hepatic stellate cells model were applied for the study of experimental fibrosis.
    [Liver International]

    Abstract

    SGOL2 Is a Novel Prognostic Marker and Fosters Disease Progression via a MAD2-Mediated Pathway in Hepatocellular Carcinoma

    Scientists examined the potential role of SGOL2 in cancers, especially in HCC. Immunohistochemistry, immunofluorescence, western blot, o-immunoprecipitation technique, and bioinformatic analysis were utilized to assess the role of SGOL2 in HCC development process.
    [Biomarker Research]

    Full Article

    LINC01468 Drives NAFLD-HCC Progression through CUL4A-Linked Degradation of SHIP2

    In vitro and in vivo gain- and loss-of-function experiments showed that LINC01468 promoted the proliferation of HCC cells through lipogenesis.
    [Cell Death Discovery]

    Full Article

    Knockdown of the Long Noncoding RNA PURPL Induces Apoptosis and Sensitizes Liver Cancer Cells to Doxorubicin

    Investigators performed RNA sequencing of liver biopsies from ten HCC, ten hepatitis C virus-associated HCC, and four normal livers to identify dysregulated lncRNAs in HCC.
    [Scientific Reports]

    Full Article

    Gemigliptin Alleviates Succinate-Induced Hepatic Stellate Cell Activation by Ameliorating Mitochondrial Dysfunction

    To clarify the effects and mechanisms of gemigliptin, the authors conducted various experiments in LX-2 cells, which were activated by succinate and exhibited elevated expression of α-smooth muscle actin, collagen type 1, and pro-inflammatory cytokines and increased cell proliferation.
    [Endocrinology and Metabolism]

    Abstract

    Design, Synthesis and Biological Evaluation Studies of Novel Anti-Fibrosis Agents Bearing Sulfoxide Moiety

    Among a series of novel small-molecule compounds, a potential anti-fibrosis drug compd.1 was founded to be able to dose-dependently down-regulate ACTA2 and CTGF mRNA levels in human hepatic stellate cells treated with TGF-β.
    [Bioorganic & Medicinal Chemistry]

    AbstractGraphical Abstract
    Connect with us via LiveChat to ask your scientific support questions
    REVIEWS

    Evolving Therapeutic Landscape of Advanced Hepatocellular Carcinoma

    Investigators summarize the latest clinical advances in the treatment of advanced HCC and discuss future perspectives that might inform the development of more effective therapeutics for advanced HCC.
    [Nature Reviews Gastroenterology & Hepatology]

    Full Article

    Is Liver Regeneration Key in Hepatocellular Carcinoma Development?

    The authors review the mechanisms of hepatic regeneration and their potential to influence HCC development.
    [Trends in Cancer]

    Abstract

    Protein Phosphatases Regulate the Liver Microenvironment in the Development of Hepatocellular Carcinoma

    Scientists highlight the importance of protein phosphatases in HCC development and in the regulation of the cellular components in the liver microenvironment and to show their significance as therapeutic targets.
    [Experimental and Molecular Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Escient Pharmaceuticals Initiates Phase II PACIFIC Study Evaluating EP547, An Oral MRGPRX4 Antagonist, in Subjects with Cholestatic Pruritus

    Escient Pharmaceuticals announced the initiation of a Phase II clinical study of EP547 in subjects with cholestatic pruritus. EP547 is a highly selective antagonist of MRGPRX4, a cell surface receptor expressed on sensory neurons that is activated by bile acids, bilirubin and other heme metabolite.
    [Escient Pharmaceuticals]

    Press Release

    German Scientist, Inventor of World’s 1st Treatment for Hepatitis D, Chosen for Blumberg Prize by Hepatitis B Foundation

    The Hepatitis B Foundation, a global nonprofit organization, today announced that Stephan Urban, PhD, distinguished professor and globally recognized virologist, has been chosen to receive its 2023 Baruch S. Blumberg Prize.
    [Hepatitis B Foundation]

    Press Release
    FEATURED EVENT

    Stem Cells: Advances in the Application of Stem Cells and Their Role In Vivo

    February 5 – 8, 2023
    Keystone, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Senior Program Associate – Science in the City

    STEMCELL Technologies, Inc. – Boston, Massachusetts, United States

    Postdoc Position – Cell Competition in Human In Vitro Systems

    University of Bristol – Bristol, United Kingdom

    Lecturer – Cell and Developmental Biology

    Imperial College London – London, England, United Kingdom

    PhD Candidate – Spatial and Single Cell Transcriptomics

    Helmholtz Munich – Neuherberg, Germany

    Senior Scientist – Receptor Pharmacology and Cell Signaling

    Novo Nordisk – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter